Cognitive impairment in Huntington disease: Diagnosis and treatment

Current Neurology and Neuroscience Reports

Volumn 11, Issue 5, 2011, Pages 474-483

  Paulsen, Jane S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cognitive impairment; Dementia; Diagnosis; Huntington disease; Mild cognitive impairment; Prodrome of HD

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; COGNITIVE DEFECT; COMMUNICATION DISORDER; DYSEXECUTIVE BEHAVIOR; EARLY DIAGNOSIS; EMOTION RECOGNITION DEFICIT; EXECUTIVE FUNCTION; HUMAN; HUNTINGTON CHOREA; IMPLICIT MEMORY; LEARNING MEMORY; MEMORY; MEMORY DISORDER; MENTAL TASK; MILD COGNITIVE IMPAIRMENT; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NONHUMAN; OLFACTORY DISCRIMINATION; PERCEPTION DISORDER; SELF CONCEPT; SMELLING DISORDER; THINKING; TIME PERCEPTION; WORKING MEMORY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AWARENESS; COGNITION DISORDERS; COMMUNICATION; DISABILITY EVALUATION; EMOTIONS; EXECUTIVE FUNCTION; HUMANS; HUNTINGTON DISEASE; MEMORY; NEUROPSYCHOLOGICAL TESTS; SMELL;

EID: 81055156193     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0215-x     Document Type: Article

References (92)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971-83.
2. Ferrante RJ, Kowall NW, Beal MF, et al. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 1985;230(4725):561-3. (Pubitemid 16169813)
3. Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett. 1991;133(2):257-61.
4. Aylward EH, Nopoulos PC, Ross CA, et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2011;82:405-10.
5. Rosas HD, Hevelone ND, Zaleta AK, et al. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology. 2005;65(5):745-7. (Pubitemid 41285856)
6. Paulsen JS, Magnotta VA, Mikos AE, et al. Brain structure in preclinical Huntington's disease. Biol Psychiatry. 2006;59(1):57-63. (Pubitemid 43005236)
7. Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis. 2010;5(1):40.
8. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10 (1):83-98.
9. Paulsen JS, Hayden M, Stout JC, et al. Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol. 2006;63 (6):883-90. (Pubitemid 43882298)
10. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79(8):874-80.
11. Nance MA, Paulsen JS, Rosenblatt A, Wheelock V. A physician's guide to the management of Huntington's disease. 3rd ed. Huntington's Disease Society of America 2011.
12. Paulsen JS, Zhao H, Stout JC, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology. 2001;57(4):658-62. (Pubitemid 32782994)
13. Langbehn DR, Paulsen JS. Predictors of diagnosis in Huntington disease. Neurology. 2007;68(20):1710-7. (Pubitemid 46763259)
14. Biglan KM, Ross CA, Langbehn DR, et al. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICTHD study. Mov Disord. 2009;24(12):1763-72.
15. Paulsen JS, Nopoulos PC, Aylward E, et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull. 2010;82(3-4):201-7.
16. Aylward EH, Sparks BF, Field KM, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 2004;63 (1):66-72. (Pubitemid 38943780)
17. Unified Huntington's disease rating scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996;11(2):136-142.
18. Carlozzi NE, Stout JC, Mills JA, et al. Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease. Clin Neuropsychol. 2011;25(5):757-77.
19. O'Rourke JJ, Adams WH, Duff K, et al. Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest. Arch Clin Neuropsychol. 2011;26(1):59-66.
20. Petersen RC. Conversion. Neurology. 2006;67(9 Suppl 3):S12-13. (Pubitemid 44684671)
21. Duff K, Beglinger LJ, Theriault D, et al. Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol. 2009;1-9.
22. Paulsen JS, Duff K. Extending MCI beyond Alzheimer disease. Neurology. 2009;72(13):1116-7.
23. Peavy GM, Jacobson MW, Goldstein JL, et al. Cognitive and functional decline in Huntington's disease: Dementia criteria revisited. Move Disord. 2010;25(9):1163-1169.
24. Mickes L, Jacobson M, Peavy G, et al. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord. 2010;25(13):2229-33.
25. Hamilton JM, Salmon DP, Corey-Bloom J, et al. Behavioural abnormalities contribute to functional decline in Huntington's disease. J Neurol Neurosurg Psychiatry. 2003;74(1):120-2. (Pubitemid 36069050)
26. Nehl C, Paulsen JS. Huntington Study Group: cognitive and psychiatric aspects of Huntington disease contribute to functional capacity. J Nerv Ment Dis. 2004;192(1):72-4. (Pubitemid 38101701)
27. Williams JK, Barnette JJ, Reed D, et al. Development of the Huntington disease family concerns and strategies survey from focus group data. J Nurs Meas. 2010;18(2):83-99.
28. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol. 2004;25(10):1715-21. (Pubitemid 44123696)
29. Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137-42.
30. Lemay M, Fimbel E, Beuter A, et al. Sensorimotor mapping affects movement correction deficits in early Huntington's disease. Exp Brain Res. 2005;165(4):454-60. (Pubitemid 41224986)
31. Say MJ, Jones R, Scahill RI, et al. Visuomotor integration deficits precede clinical onset in Huntington's disease. Neuropsychologia 2011;49(2):264-270.
32. Tabrizi SJ, Scahill RI, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10(1):31-42.
33. Solomon AC, Stout JC,Weaver M, et al. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord. 2008;23(13):1830-6.
34. Rupp J, Blekher T, Jackson J, et al. Progression in Prediagnostic Huntington Disease. J Neurol Neurosurg Psychiatry. 2010;81 (4):379-84.
35. Paulsen J. Early detection of Huntington's disease. Future Neurology. 2010;5(1):85-104.
36. Hinton SC, Paulsen JS, Hoffmann RG, et al. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc. 2007;13(3):539-43. (Pubitemid 47307494)
37. Zimbelman JL, Paulsen JS, Mikos A, et al. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc. 2007;13(5):758-69. (Pubitemid 47299445)
38. Rowe KC, Paulsen JS, Langbehn DR, et al. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology 2010;24(4):435-442.
39. Jin X, Costa RM. Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature. 2010;466(7305):457-62.
40. Stout JC, Paulsen JS, Queller S, et al. Neurocognitive signs in prodromal huntington disease. Neuropsychology 2011;25(1):1-14.
41. Bechtel N, Scahill RI, Rosas HD, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010;75(24):2150-60.
42. Johnson SA, Stout JC, Solomon AC, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain. 2007;130(Pt 7):1732-44. (Pubitemid 47343802)
43. Snowden JS, Austin NA, Sembi S, et al. Emotion recognition in Huntington's disease and frontotemporal dementia. Neuropsychologia. 2008;46(11):2638-49.
44. Henley SMD, Wild EJ, Hobbs NZ, et al. Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia. 2008;46(8):2152-60.
45. de Gelder B, Van den Stock J, Balaguer RdD, Bachoud-Lévi A-C. Huntington's disease impairs recognition of angry and instrumental body language. Neuropsychologia. 2008;46(1):369-73.
46. Calder AJ, Keane J, Young AW, et al. The relation between anger and different forms of disgust: Implications for emotion recognition impairments in Huntington's disease. Neuropsychologia 2010;48(9):2719-2729.
47. Hamilton JM, Murphy C, Paulsen JS. Odor detection, learning, and memory in Huntington's disease. J Int Neuropsychol Soc. 1999;5(7):609-15. (Pubitemid 30047686)
48. Bacon Moore AS, Paulsen JS, Murphy C. A test of odor fluency in patients with Alzheimer's and Huntington's disease. J Clin Exp Neuropsychol. 1999;21(3):341-51. (Pubitemid 29447786)
49. Nordin S, Paulsen JS, Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc. 1995;1(3):281-90.
50. Montoya A, Pelletier M, Menear M, et al. Episodic memory impairment in Huntington's disease: a meta-analysis. Neuropsychologia. 2006;44(10):1984-94. (Pubitemid 43927985)
51. Solomon AC, Stout JC, Johnson SA, et al. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia. 2007;45(8):1767-76. (Pubitemid 46386118)
52. Sadek JR,White DA, Taylor KI, et al. Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer's disease, and Huntington's disease. Neuropsychology. 2004;18(4):692-9. (Pubitemid 39363155)
53. Paulsen JS, Butters N, Sadek JR, et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology. 1995;45(5):951-6.
54. Paulsen JS, Butters N, Salmon DP, et al. Prism adaptation in Alzheimer's and Huntington's Disease. Neuropsychology. 1993;7 (1):73-81.
55. Carella F, Bressanelli M, Piacentini S, et al. A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions. Neurol Sci. 2003;23(6):287-93. (Pubitemid 36336058)
56. Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci. 2006;31(1):21-9.
57. Filoteo JV, Delis DC, Roman MJ, et al. Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. J Clin Exp Neuropsychol. 1995;17(5):654-67.
58. Nehl C, Ready RE, Hamilton J, Paulsen JS. Effects of depression on working memory in presymptomatic Huntington's disease. J Neuropsychiatry Clin Neurosci. 2001;13(3):342-6. (Pubitemid 32743712)
59. Thompson JC, Poliakoff E, Sollom AC, et al. Automaticity and attention in Huntington's disease: when two hands are not better than one. Neuropsychologia 2010;48(1):171-178.
60. Smith MM, Long JD. Cognitive changes in prodromal Huntington Disease. Unpublished manuscript 2011, The University of Iowa Department of Psychiatry.
61. Duff K, Beglinger LJ, Schultz SK, et al. Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index. Arch Clin Neuropsychol. 2007;22(1):15-24. (Pubitemid 46209588)
62. Dutilh G, Krypotos AM, Wagenmakers EJ. Task-related versus stimulus-specific practice. Exp Psychol. 2011;1-9.
63. Rosenblatt A, Kumar BV, Margolis RL, et al. Factors contributing to institutionalization in patients with Huntington's disease. Mov Disord. 2011;Epub ahead of print. doi:10.1002/mds.23716.
64. O'Rourke JJ, Beglinger LJ, Smith MM, et al. The trail making test in prodromal Huntington disease: Contributions of disease progression to test performance. J Clin Exp Neuropsychol. 2011;33(5):567-579.
65. Paulsen JS, Salmon DP, Monsch AU, et al. Discrimination of cortical from subcortical dementias on the basis of memory and problem-solving tests. J Clin Psychol. 1995;51(1):48-58.
66. Beglinger LJ, Nopoulos PC, Jorge RE, et al. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol. 2005;18(2):102-7. (Pubitemid 40946422)
67. Monsch AU, Bondi MW, Butters N, et al. A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease. Neuropsychology. 1994;8(1):25-30.
68. Duff K, Paulsen JS, Beglinger LJ, et al. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci. 2010;22(2):196-207.
69. Paulsen JS, Stout JC, DeLaPena JH, et al. Frontal behavioral syndromes in cortical and subcortical dementia. Assessment. 1996;3(3):327-37. (Pubitemid 126696135)
70. Paulsen JS, Stout JC, Tawfik-Reedy Z, et al. (editors). The utility of the Frontal Lobe Personality Scale (FLOPS) for characterizing behavior in dementia of the Alzheimer's type (DAT) and Huntington's disease (HD). Arch Clin Neuropsychol. 1996.
71. Hartelius L, Jonsson M, Rickeberg A, Laakso K. Communication and Huntington's disease: qualitative interviews and focus groups with persons with Huntington's disease, family members, and carers. Int J Lang Commun Disord. 2010;45(3):381-93.
72. Rohrer D, Salmon DP, Wixted JT, Paulsen JS. The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory. Neuropsychology. 1999;13(3):381-8. (Pubitemid 29382609)
73. Chenery HJ, Copland DA, Murdoch BE. Complex language functions and subcortical mechanisms: evidence from Huntington's disease and patients with non-thalamic subcortical lesions. Int J Lang Commun Disord. 2002;37(4):459-74. (Pubitemid 35238690)
74. Saldert C, Fors A, Ströberg S, Hartelius L. Comprehension of complex discourse in different stages of Huntington's disease. Int J Lang Commun Disord. 2010;45(6):656-69.
75. Ferm U, Sahlin A, Sundin L, Hartelius L. Using talking mats to support communication in persons with Huntington's disease. Int J Lang Commun Disord. 2010;45(5):523-36.
76. Deckel AW, Morrison D. Evidence of a neurologically based "denial of illness" in patients with Huntington's disease. Arch Clin Neuropsychol. 1996;11(4):295-302.
77. McGlynn SM. Behavioral approaches to neuropsychological rehabilitation. Psychol Bull. 1990;108(3):420-41.
78. Snowden JS, Craufurd D, Griffiths HL, Neary D. Awareness of involuntary movements in Huntington disease. Arch Neurol. 1998;55(6):801-5. (Pubitemid 28265696)
79. Vitale C, Pellecchia MT, Grossi D, et al. Unawareness of dyskinesias in Parkinson's and Huntington's diseases. Neurol Sci. 2001;22(1):105-6. (Pubitemid 33622099)
80. Ho AK, Robbins AO, Barker RA. Huntington's disease patients have selective problems with insight. Mov Disord. 2006;21 (3):385-9.
81. Hoth KF, Paulsen JS, Moser DJ, et al. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol. 2007;29(4):365-76. (Pubitemid 46763628)
82. Mestre T, Ferreira J, Coelho MM, et al. Therapeutic interventions for disease progression in Huntington's disease. Cochrane Database Syst Rev. 2009;(3):CD006455.
83. Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics. 2008;5(2):181-97. (Pubitemid 351446213)
84. Beglinger LJ, Adams WH, Paulson H, et al. Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease. J Clin Psychopharmacol. 2009;29(5):484-7.
85. Vaccarino AL, Anderson K, Borowsky B, et al. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers. Mov Disord. 2011;26(5):877-84.
86. Vaccarino AL, Sills T, Borowsky B, et al. Assessment of cognitive symptoms in prodromal and early huntington disease. PLoS Currents: Huntington Disease [Internet Knol] 2011 Jun 21, Version 101: http://knol.google.com/k/ anthony-l-vaccarino/assessment-ofcognitive-symptoms-in/19jerwgzmryar/16.
87. Vaccarino AL, Sills T, Anderson KE, et al. Assessing behavioural manifestations prior to clinical diagnosis of huntington disease: "anger and irritability" and "obsessions and compulsions". PLoS Currents: Huntington Disease [Internet] 2011 Mar 30 [revised 2011 Jun 13] Version 141: http://knol.google.com/k/anthony-l-vaccarino/assessing-behavioural- manifestations/19jerwgzmryar/19.
88. Vaccarino AL, Sills T, Anderson KE, et al. Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS Currents: Huntington Disease [Internet] 2011 Apr 7 [revised 2011 Jun 17] Version 94: http://knol.google.com/k/anthony-l-vaccarino/assessment-of-depression-anxiety- and/19jerwgzmryar/11.
89. Vaccarino AL, Sills T, Anderson KE, et al. Assessment of motor symptoms and functional impact in prodromal and early huntington disease. PLoS Currents: Huntington Disease [Internet] 2011 Jun 14, Version 209: http://knol.google.com/ k/anthony-l-vaccarino/assessment-of-motor-symptoms-and/19jerwgzmryar/11.
90. Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers of Medicine. 2010;4 (6):871-87.
91. Saleh N, Moutereau S, Azulay JP, et al. High insulinlike growth factor I is associate with cognitive decline in Huntington disease. Neurology. 2010;75(1):57-63.
92. Rowe KC, Paulsen JS, Langbehn DR, et al. Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Res. 2011;In press.